User profiles for Philip N Britton
PN BrittonUniversity of Sydney Verified email at health.nsw.gov.au Cited by 4397 |
Vaccines for COVID-19: The current state of play
…, YJ Joo, A Khatami, C Chiu, PN Britton - Paediatric respiratory …, 2020 - Elsevier
There is a strong consensus globally that a COVID-19 vaccine is likely the most effective
approach to sustainably controlling the COVID-19 pandemic. An unprecedented research effort …
approach to sustainably controlling the COVID-19 pandemic. An unprecedented research effort …
Off-season RSV epidemics in Australia after easing of COVID-19 restrictions
Human respiratory syncytial virus (RSV) is an important cause of acute respiratory infection
with the most severe disease in the young and elderly. Non-pharmaceutical interventions …
with the most severe disease in the young and elderly. Non-pharmaceutical interventions …
COVID-19 public health measures and respiratory syncytial virus
In New South Wales (NSW), Australia, the public health response was highly effective in
controlling the early phase of the COVID-19 pandemic. 1 During this time, clinicians reported …
controlling the early phase of the COVID-19 pandemic. 1 During this time, clinicians reported …
COVID‐19 in children. II: pathogenesis, disease spectrum and management
…, K Sharma, DK Yeoh, PN Britton - … of paediatrics and …, 2022 - Wiley Online Library
The global disruption of the COVID‐19 pandemic has impacted the life of every child either
directly or indirectly. This review explores the pathophysiology, immune response, clinical …
directly or indirectly. This review explores the pathophysiology, immune response, clinical …
RSV epidemiology in Australia before and during COVID-19
…, W Rawlinson, A Kesson, R Lingam, PN Britton - …, 2022 - publications.aap.org
… Drs Britton, Lingam, and Homaira conceptualized and designed the study, oversaw data
analysis and interpretation, and reviewed and revised the manuscript; Dr Hu conceptualized …
analysis and interpretation, and reviewed and revised the manuscript; Dr Hu conceptualized …
Vaccines for COVID-19: Where do we stand in 2021?
…, K Nicolopoulos, C Chiu, N Wood, PN Britton - Paediatric respiratory …, 2021 - Elsevier
As of July 2021, over 3 billion doses of a COVID-19 vaccines have been administered
globally, and there are now 19 COVID-19 vaccines approved for use in at least one country. …
globally, and there are now 19 COVID-19 vaccines approved for use in at least one country. …
Parechovirus encephalitis and neurodevelopmental outcomes
OBJECTIVE: We aimed to describe the clinical features and outcome of human parechovirus
(HPeV) encephalitis cases identified by the Australian Childhood Encephalitis (ACE) study. …
(HPeV) encephalitis cases identified by the Australian Childhood Encephalitis (ACE) study. …
Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines
Few studies are available to inform duration of intravenous antibiotics for children and when
it is safe and appropriate to switch to oral antibiotics. We have systematically reviewed …
it is safe and appropriate to switch to oral antibiotics. We have systematically reviewed …
COVID‐19 in children: I. Epidemiology, prevention and indirect impacts
…, S Tosif, D Wurzel, PN Britton - … of Paediatrics and …, 2022 - Wiley Online Library
Children globally have been profoundly impacted by the coronavirus disease 2019 (COVID‐19)
pandemic. This review explores the direct and indirect public health impacts of COVID‐…
pandemic. This review explores the direct and indirect public health impacts of COVID‐…
SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings
As the SARS-CoV-2 pandemic unfolds across the globe, consistent themes are emerging with
regard to aspects of SARS-CoV-2 infection and its associated disease entities in children. …
regard to aspects of SARS-CoV-2 infection and its associated disease entities in children. …